NLM Logo

Cytarabine MeSH Descriptor Data 2022


MeSH Heading
Cytarabine
Tree Number(s)
D03.383.742.680.245.453
D13.570.065.300
D13.570.685.245.453
Unique ID
D003561
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D003561
Scope Note
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
Entry Term(s)
Ara-C
Arabinofuranosylcytosine
Arabinosylcytosine
Aracytidine
Aracytine
Cytarabine Hydrochloride
Cytonal
Cytosar
Cytosar-U
Cytosine Arabinoside
beta-Ara C
Pharm Action
Antimetabolites, Antineoplastic
Antiviral Agents
Immunosuppressive Agents
Registry Number
04079A1RDZ
Related Numbers
147-94-4
33K3DB6591
69-74-9
CAS Type 1 Name
2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-
NLM Classification #
QV 269
See Also
Decitabine
Public MeSH Note
1966
History Note
1966
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2018/02/28
Cytarabine Preferred
beta-Ara C Narrower
Cytarabine Hydrochloride Narrower
Cytosar Narrower
Ara-C Narrower
Aracytine Narrower
Cytonal Narrower
page delivered in 0.178s